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Macrophages play a crucial role in the defense against tumors and parasites.
Activation of tumoricidal and microbicidal effector mechanisms requires stimu-
lation of macrophages with macrophage-activating factors (MAF). One such
MAF is interferon y (IFN-y). In some assays, substantial activity of IFN-y on
murine macrophages, however, is only observed in synergy with lipopolysaccha-
ride (LPS) or other cytokines (1). In addition, certain cytokines have been shown
to induce monocyte or macrophage activation in the absence of IFN-y (2-5). We
previously described lymphokines in the supernatant of a murine T cell clone
that synergized with IFN-y in the induction of tumoricidal and schistosomulicidal
murine macrophages (1). We called this lymphokine(s) macrophage cytotoxicity-
inducing factor 2 (MCIF2) (1). A candidate for MCIF2 was lymphotoxin (LT),
because the T cell clone supernatant contained high amounts of LT. LT is
functionally homologous and structurally related to the macrophage product
tumor necrosis factor (TNF). Therefore, we tested whether recombinant (r) LT
or rTNF can function as MAF. We report here that rLT or rTNF synergize
with rIFN-y in the induction of tumoricidal and schistosomulicidal murine
macrophages.
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Reagents and Cytokines.
￿
Bacterial LPS (from Shigella fexneri) was purchased from
Sigma Chemical Co. (Deisenhofen, Federal Republic of Germany). Human rTNF was a
gift from BASF, Ludwigshafen (Federal Republic of Germany); human rLT was a gift
provided by Genentech (2715/88, specific activity 3 x 107 U/mg; South San Francisco,
CA). The ?ecifc activity of rTNF tested on actinomycin D-treated mouse L929 cells
was 2 x 10 U/mg. rLT and rTNF showed the same specific activity as to lysis of L929
cells.
Macrophage TumorCell and Schistosomula Killing.
￿
As described previously (1), resident
peritoneal macrophages from C3H/Hej mice (2.5 x 105 peritoneal cells) were cultured
in 200 j1 of medium. After 2 h, nonadherent cells were removed and the remaining
adherent cells (>95% macrophages by nonspecific esterase staining) were incubated
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overnight in the presence of serial dilutions of rLT or rTNF in the presence or absence
of rIFN-y. After two washes of the cells, 4 X 104 6-[3H]TdR-labeled P815 target cells
(Amersham Corp., Braunschweig, Federal Republic of Germany, sp act, 5.0 Ci/mmol; 4
hat 37°C in 5% C02; 10 pCi per 106 cells) in 200 ,ul medium were added. After 20 h of
incubation, [5H]TdR release was determined. The percent specific P815 killing was
calculated as 100 X [(experimental release) - (control release)]/[(maximum release) -
(control release)]. Schistosomula killing using skin schistosomula from a Puerto Rican
strain of Schistosoma mansoni has previously been described (1) and was performed in the
same way as the tumoricidal assay except that 200 ul of a schistosomula suspension (100
larvae) were added to the macrophages preincubated with the corresponding cytokines.
The viability of schistosomula was visually determined after 24 h of culture.
Tumor Cell Killing with Bone Marrow-derived Macrophages. Cells from femurs of
C3H/HeJ mice were incubated for 10 d at a concentration of 3 X 105 cells/ml in Petri
dishes (non-tissue culture grade; Greiner and S6hne, Nurtingen, Federal Republic of
Germany) in RPMI 1640 supplemented with L-glutamine (2 mM), streptomycin (100
ug/ml), penicillin (100 U/ml), essential amino acids (50 wg/ml), nonessential amino acids
(50,ug/ml), 5% heat-inactivated horse serum, 10% heat-inactivated FCS, and 20% Lcell-
conditioned medium with two changes of culture medium on days 5 and 8. The cells
(100% nonspecific esterase-positive) were detached by gentle pipetting with cold PBS
(Ca" and Mg" free), washed, and resuspended in RPMI 1640 medium supplemented
with L-glutamine (2 mM), streptomycin (100 Ag/ml), penicillin (100 U/ml), and 10% FCS.
105 cells/culture were used for tumor cell killing.
Chemiluminescence (CL) by Bone Marrow-derived Macrophages.
￿
3 X 105 cells in 0.5 ml
medium were added to cylindrical glass tubes and incubated for 18 h in the presence of
medium alone or medium containing cytokines. The cells were then washed and CL
measured at 37°C in Dulbecco's PBS supplemented with BSA (1 mg/ml), glucose (1
mg/ml), luminol (20 AM), and PMA (100 nM).
Results and Discussion
Induction of Tumoricidal and Schistosomulicidal Murine Resident Peritoneal Mac-
rophages with rIFN-y and rLTor rTNF. We tested several recombinant cytokines
for in vitro activation of tumoricidal and schistosomulicidal macrophages. Puri-
fied murine rIL-1, rIL-3, and purified natural murine IL-2 (3-100 U/ml) in the
presence or absence of murine rIFN-y (20 U/ml) failed to induce macrophage
activation. Likewise, rIFN-y at a concentration up to 100 U/ml was inactive.
rIFN-y (20 U/ml), however, served as a priming signal in the presence of LPS
as the triggering signal (data not shown). In contrast, human rLT and rTNF,
active on mouse cells, synergized with rIFN-y in the induction of both macro-
phage activities (Fig. 1) . In the absence of rIFN-y, no effect was observed with
rLT or rTNF up to a concentration of 10 ug/ml (Fig. 1). The effective amounts
of rLT and rTNF to induce a 50% cytotoxic response varied in a wide range of
concentrations depending on each particular experiment (2-250 ng/ml; 12
experiments). Induction of macrophage activation by rIFN-y and rLT or rTNF
was not due to contamination with LPS, because the concentrations of LPS
present in the rIFN-y, rLT, and rTNF preparations used (<1.0 ng/ml) were
inactive. In addition, macrophage activation was not impaired in the presence of
polymyxin B (50 ug/ml), neutralizing at least 200 ng/ml of LPS in the macro-
phage tumoricidal assay (data not shown). Furthermore, in most experiments
and in the experiments shown here we used macrophages from C3H/HeJ mice
(LPS low responder). Finally, treatment of rLT or rTNF at 100°C for 10 min
destroyed the capacity of these cytokines to induce tumoricidal and schistoso-1001
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FIGURE 1 . Induction of tumorici-
dal (a)and schistosomulicidal (b)mu-
rine resident peritoneal macrophages
upon incubation with differentdoses
-
￿
of rLT (Q) or rTNF (0) in the pres-
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ence (solid lines) or absence (dashed
lines) of rIFN-y (20 U/ml). The per-
centage of specific killing for each
point represents the mean of tripli-
cate samples. The standard errors
were <5% of the mean value. The
results are from a representative ex-
periment out of 12.
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mulicidal macrophages. Such heat treatment, however, does not destroy LPS
activity. Taken together, these data show that macrophage activation in our
experiments was induced by rIFN-7 and rLT or rTNF and not by rIFN-y and
contaminating LPS.
Induction of Tumoricidal Murine Bone Marrow-derived Macrophages with rIFN-y
and rLT or rTNF. Similar data as with adherent peritoneal cells were obtained
with pure macrophages from 10-d bone marrow cell cultures. Fig. 2 shows that
such cells killed P815 tumor cells upon activation by rLT or rTNF only in
synergy with rIFN-y. Thus, macrophage activation by rIFN-y and rLT or rIFN-
y and rTNF is mediated through the direct action of these cytokines on
macrophages.
Lack of P815 Tumor Cell Lysis and Schistosomula Killing by rIFN-y and rLT or
rTNF in the Absence of Macrophages. The above experiments did not formally
distinguish between the possible dual role of LT and TNF as inducers of
macrophage functions and as cytolytic molecules (6, 7). Furthermore, a synergy
between IFN-y and TNF or LT for direct tumor cell cytotoxicity has previously
been documented (8). Therefore, we devised experiments to show that the592
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FIGURE 2.
￿
Induction of tumor-
icidal murine bone marrow-de-
rived macrophages upon incuba-
tion with different doses of rLT
(Q) or rTNF (0) in the presence
(solid lines) or absence (dashed
lines) of rIFN-,y (20 U/ml). The
results are from one representa-
tive experiment outof five.
stimuli provided by rLT or rTNF in synergy with rIFN-y were truly inductive.
P815 tumor cells were resistant and schistosomula not killed within 20 h of
incubation with rIFN-y (20 U/ml) and rLT (0.075-5,ug/ml) or rTNF (0.075-5
Ag/ml) in the absence of macrophages. rTNF alone had no effect. Longer
incubation (72 h) of P815 tumor cells with rIFN-y (20 U/ml) and rTNF (0.025-
2.5 Ag/ml) was also not effective. Schistosomula were even resistant to direct
cytotoxicity of rTNF, when their efficient damage repair system was blocked
with actinomycin D (50 leg/ml), cycloheximide (10 kg/ml), colchicine (50 hg/ml),
or mithramycin A (10 ttg/ml). However, under the same conditions but with
resident peritoneal macrophages, pronounced tumoricidal (60-62% killing) and
schistosomulicidal (82-95% killing) effects were observed. Similar results were
obtained with comparable doses of rLT. In addition, macrophages were incu-
bated with rIFN-y and rLT or rTNF at doses that induce macrophage cytotox-
icity and subsequently fixed with formaldehyde . These cells failed to kill P815
tumor cells or schistosomula. These results show that killing is exerted only by
viable, activated macrophages and is unlikely to be explained by the mere
absorption of rLT or rTNF to the macrophage surface.
CL by Bone Marrow-derived Macrophages with rIFN-,y and rLT or rTNF.
￿
To
further support our contention that rIFN-,y and rLT or rTNF were not merely
cytotoxic but inducers of macrophage activation, we examined a macrophage
function different from tumor or parasite killing, namely the release of oxygen
intermediates by activated macrophages (9). Theactivity ofrTNF and rLT (both
in the presence or absence of rIFN-y) on the oxidative respiratory burst of
macrophages in a PMA-triggered, luminol-dependent CL assay was tested. Fig.
3 shows that bone marrow-derived macrophages preincubated during 18 h with
rIFN--y (20 U/ml) and rTNF (100 ng/ml) demonstrated enhanced CL as com-
pared to cells preincubated with either lymphokine alone. Experiments with
rIFN-,y and rLT gave superimposable CL curves (data not shown). This effect
was specific for rTNF or rLT, since preincubation in the presence of rIFN-y
and IL-2 did not show this effect. Taken together, these data demonstrate that
LT and TNF synergize with IFN-y to directly induce tumoricidal and schisto-
somulicidal macrophages. Thus, MCIF2 present in T cell supernatant andESPARZA ET AL .
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FIGURE 3. Chemiluminescence by
bone marrow-derived macrophages
upon incubation with different cyto-
kines . The cells were incubated in the
presence of medium alone (V) or me-
dium containing : purified natural
murine IL-2 (100 U/ml) (18) (0),
rIFN-y (20 U/ml) (" ), rTNF (100
ng/ml) (--0-), rIFN-y (20 U/ml) +
natural IL-2 (100 U/ml) (" ), rIFN-y
(20 U/ml) + rTNF (100 ng/ml)
-) . The shaded area represents
backgroundCL in the absence of the
inducerPMA.
synergizing with IFN-y could be LT . Whether yet other T cell-derived MAF
apart from IFN-y and LT exist and whether IFN-y and LT act as priming and
triggering signal, respectively, remains to be shown . Previous papers have shown
a synergy between rIFN-y and rLT or rTNF for (a) an antiproliferative effect
on different normal and transformed cell lines (10), (b) the induction of NK-
mediated target cell killing (11), (c) an inhibition ofgranulocyte/monocyte colony
formation (14), and (d) a differentiation of human myeloid cell lines (13) . Our
data show that properties of LT and TNF as immunomodulators include induc-
tion of tumoricidal and schistosomulicidal macrophages . IFN-y and LT are
lymphokines secreted by activated T lymphocytes . Therefore, macrophage tu-
moricidal and parasiticidal activity could arise in vivo in the course of a T cell-
mediated immune response . In addition, TNF is released by macrophages
themselves upon stimulation with bacterial endotoxins (LPS) (14-16), or as a
result of a virus infection (17) . Thus, TNF could act eitheron other macrophages
or in an autocrine manner on the same cell that produced it (6) . This might
result in resistance to a further viral or microbial infection .
We thank Ilona Wesch for excellent technical and Heidi Sauter for excellent secretarial
assistance, and Drs . E. Storch and M . Hergenhahn for help with preparation of the bone
marrow-derived macrophages and with the investigation of chemiluminescence, respec-
tively .
Receivedfor publication 13 March 1987 and in revisedform 30 April 1987 .
References
1 . Krammer, P . H ., C . F . Kubelka, W . Falk, and A . Ruppel . 1985 . Priming and
triggering of tumoricidal and schistosomulicidal macrophages by two sequential
lymphokine signals : Interferon--y and macrophage cytotoxicity inducing factor 2 . J.
Immunol. 135:3258 .
2 . Nacy, C . A ., A . H . Fortier, M . S . Meltzer, N . A . Buchmeier, and R . D . Schreiber .
1985 . Macrophage activation to kill Leishmania major: Activation of macrophages for
intracellular destruction of amastigotes can be induced by both recombinant IFN-y
and non-interferon lymphokines . J. Immunol . 135:3505 .594
￿
ESPARZA ET AL.
￿
BRIEF DEFINITIVE REPORT
3. Hoover, D. L., D. S. Finbloom, R. M. Crawford, C. A. Nacy, M . Gilbreath, and M .
S. Meltzer. 1986. A lymphokine distinct from interferon-gamma that activates human
monocytes to kill Leishmania donovani in vitro.J. Immunol. 136:1329.
4. Lee, J. C ., L. Rebar, P. Young, F. W. Ruscetti, N. Hanna, and G. Poste. 1986.
Identification and characterization of a human T cell-line derived lymphokine with
MAF-like activity distinct from interferon-gamma] Immunol. 136:1322.
5. Grabstein, K. H ., D. L. Urdal, R. J . Tushinski, D. Y. Mochizuki, V. L. Price, M. A.
Cantrell, S. Gillis, and P. J. Conlon. 1986. Induction of macrophage tumoricidal
activity by granulocyte-macrophage colony-stimulating factor. Science (Wash. DC).
232:506.
6. Philip, R., and L. B. Epstein. 1986. Tumor necrosis factor as immunomodulator and
mediator of monocyte cytotoxicity induced by itself, gamma-IFN and interleukin-1 .
Nature (Loud.). 323:86 .
7. Urban, J. L., H . M . Shepard, J. L. Rothstein, B. J . Sugarman, and H. Schreiber.
1986. Tumor necrosis factor: a potent effector molecule for tumor cell killing by
activated macrophages. Proc. Natl. Acad. Sci. USA. 83:5233.
8 . Stone-Wolff, D. S., Y. K. Yip, H. C. Kelker, J. Le, D. Henriksen-Destefano, B. Y.
Rubin, E. Rinderknecht, B. B. Aggarwal, and J. Vilcek. 1984. Interrelationships of
human interferon-gamma with lymphotoxin and monocyte cytotoxin. J. Exp. Med.
159:828.
9 . Nathan, C. F., S. C. Silverstein, L. H. Brukner, and Z. A. Cohn. 1979. Extracellular
cytolysis by activated macrophages and granulocytes II. Hydrogen peroxide as a
mediator of cytotoxicity. J. Exp. Med. 149:100.
10. Lee, S. H ., B. B. Aggarwal, E. Rinderknecht, F. Assisi, and H. Chin. 1984 . The
synergistic anti-proliferative effect of gamma interferon and human lymphotoxin.J.
Immunol. 133:1083.
11 . Degliantoni, G., M. Murphy, M . Kobayashi, M. K. Francis, B. Perussia, and G.
Trinchieri. 1985. Natural killer (NK) cell-derived hematopoietic colony-stimulating
activity and NK cytotoxic factor.J. Exp. Med. 162 :1512.
12 . Murphy, M., R. Loudon, M. Kobayashi, and G. Trinchieri. 1986. Gamma interferon
and lymphotoxin, released by activated T cells, synergize to inhibit granulo-
cyte/monocyte colony formation. J. Exp. Med. 164:263.
13 . Trinchieri, G., M. Kobayashi, M. Rosen, R. Loudon, M. Murphy, and B. Perussia.
1986 . Tumor necrosis factor and lymphotoxin induce differentiation of human
myeloid cell lines in synergy with immune interferon. J. Exp. Med. 164:1206.
14. Mahoney, J . R., B. A. Beutler, N. Le Trang, W. Vine, Y. Ikeda, M. Kawakami, and
A. Cerami. 1985. Lipopolysaccharide-treated RAW 264.7 cells produce a mediator
that inhibits lipoprotein lipase in 3T3-L1 cells. J. Immunol. 134:1673.
15. Beutler, B., J. Mahoney, N. Le Trang, P. Pekala, and A. Cerami. 1985 . Purification
of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced
RAW 264.7 cells. J. Exp. Med. 161 :984.
16. Beutler, B., N . Krochin, I. W. Milsark, C. Luedke, and A. Cerami. 1986. Control of
cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.
Science 232:977.
17. Aderka, D., H. Holtmann, L. Toker, T. Hahn, and D. Wallach. 1986. Tumor
necrosis factor induction by Sendai virus.J. Immunol. 136:2938.
18. Falk, W., D. N. Mannel, B. Katzer, B. Kaltmann, P. H. Krammer, T. Diamantstein,
and W. Dr6ge. 1985 . Induction of IL2 receptor expression and cytotoxicity of
thymocytes by stimulation with TCF1 j Immunol. 135:1160.